U.S. FDA Approves First Cetrotide Generic

August 18, 2022

The FDA has approved Akorn’s generic version of Merck’s Cetrotide® (cetrorelix acetate for injection) 0.25mg to prevent premature ovulation during controlled ovarian stimulation.

  • Cetrotide first received FDA approval in Akorn’s 0.25mg strength generic is the first generic version of the drug.
  • Recommended dosing is 25mg once daily during the early- to mid-follicular phase.
  • Launch and pricing information are not yet available.

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager